leisure time -WSS

leisure time

author：focus 2025-09-27 23:52:49 - browse：4

Joe Biden in 2016. -- first opinion coverage from STAT — President Joe Biden Elise Amendola/AP

WASHINGTON — The latest phase of President Biden’s Cancer Moonshot initiative leaves open a few questions on how Congress might move forward with the program.

Since its launch in 2016, the federally funded cancer moonshot program has spurred thousands of scientific publications, 49 clinical trials, and more than 30 patent filings, according to a new report from the Congressional Research Service, the nonpartisan research arm of Congress.

The next phase of the cancer moonshot, according to Biden and his administration, is meant to emphasize cancer screening, prevention, and equitable treatment. The updated plan also seeks to speed progress on treatments for rare and childhood cancers, and it calls for supporting patients, survivors, and caregivers. The Advanced Research Projects Agency for Health (ARPA-H), a new agency tasked with taking big risks on biomedical and health technology, is also committing $240 million to cancer-related research and investing in new data-sharing platforms and a nationwide network for clinical trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： HHS suspends federal funding for EcoHealth Alliance

hotspot

WSS

Oak Street deal isn't the answer to health care's woes

Biden warns of ‘dark winter’ during final presidental debate

Truvian presents data for its desktop blood

Biden warns of ‘dark winter’ during final presidental debate

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

What it's like to live with paralysis for one psychologist

focus

leisure time

Wikipedia

How one medical school became remarkably diverse

Novo Nordisk testing Wegovy against alcohol

Wildfire smoke exposes gaps in outdoor worker protections

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

Medical leaders decry Supreme Court decision on affirmative action

Novo Nordisk testing Wegovy against alcohol

Supreme Court strikes down use of affirmative action

The White House hikes tariffs on plastic syringes made in China

How to save PrEP access — and even expand it

Free medical tuition alone isn't enough to close gaps in primary care

hotspot

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Cherokee Nation medical school graduates its first class

How doctors’ personal politics affect patients

CDC Director Mandy Cohen on transparency, trust, and health

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Truvian presents data for its desktop blood

leisure time

hotspot

explore

explore